Percutaneous Trigger Finger Release Concomitant Steroid Injection Versus Percutaneous Trigger Finger Release Alone
Launched by POLICE GENERAL HOSPITAL, THAILAND · Feb 23, 2024
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Material and Methods
Study Population:
Patients diagnosed with trigger finger, aged 18 years or older, and classified under Quinell's grade 2, 3, or 4, were included in the study \[ \]. Recruitment took place at the Outpatient Orthopedic Department of the Police General Hospital between October 2023 and January 2024. Exclusion criteria encompassed individuals with a history of prior hand surgery, Dupuytren's disease, type 1 diabetes, previous phalangeal fractures, recent steroid injection within the last month, and autoimmune diseases.
Group allocation and Randomization:
Patients were e...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • clinical diagnosis of trigger finger
- • aged 18 years or older
- • trigger finger are classified under Quinell's grade 2, 3, or 4
- Exclusion Criteria:
- • a history of prior hand surgery
- • Dupuytren's disease
- • type 1 diabetes
- • previous phalangeal fractures
- • recent steroid injection within the last month
- • autoimmune diseases
About Police General Hospital, Thailand
Police General Hospital in Thailand is a leading healthcare institution dedicated to advancing medical research and clinical care. As a prominent clinical trial sponsor, the hospital focuses on innovative studies aimed at improving patient outcomes across various medical disciplines. With a commitment to ethical practices and rigorous scientific standards, Police General Hospital collaborates with multidisciplinary teams to facilitate research that addresses critical health challenges. Its state-of-the-art facilities and experienced professionals ensure the highest quality of care and oversight in all clinical trial initiatives, contributing to the global medical community's knowledge and therapeutic advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkok, Pathumwan, Thailand
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported